Good MorningThe equity markets went on a wild ride on Thursday. The market was up, then down, then up and then down again all before the close of the session. The action was driven by a swirling vortex of news, data, and worry that promise to keep the markets moving in a similar fashion. On the one hand, there is evidence of a strong economic rebound while on the other worries about the virus and the upcoming election have investors on edge.
Among Thursday’s news bits was the latest read on New Home Sales. Sales of new homes defied the consensus and rose over the last month to top 1 million annualized units. The data is only the latest from the housing sector showing strength and it points to solid results from the home builders. Next week, investors will be looking for a raft of economic releases including Personal Income and Spending and the all-important Non-Farm Payroll report for September.
Featured: The 5G Revolution is #1 in 2020 (Marketing Dynamics) 
|
Markets | | |
Finding a great dividend stock to hold in your portfolio over the long-term can be a challenge in today’s market. With many companies cutting their payouts or at risk of doing so shortly, the degree of difficulty for dividend investors has gone up thanks to the pandemic and its impact on cor... Read the Full Story |
|
From Our PartnersIf you click here and get ahead of the next move you could earn $11,387 in just a few weeks… even if you only have $1,000 to trade with today. | | | | Continue Reading |
|
Stocks | | |
Say what you will about the recent market selloff. Some stocks had reached lofty valuations and were overdue for a correction. Others have been dragged down with the tide and appear to be oversold buy opportunities.
As we've seen in recent recoveries, if the market stages a rebound, it’s th... Read the Full Story |
|
Markets | | |
There are so many advantages associated with Electric Vehicles, it’s only a matter of time before we see widespread adoption of them around the world. With benefits like lower costs, less maintenance, environmental tax credits, and eco-friendliness, it makes sense that there are plenty of in... Read the Full Story |
|
From Our PartnersWarren Buffett recently dumped $800 million of Apple stock… And bought this instead! He’s now moved $3.8 BILLION in a tiny niche of the tech sector billionaires are flocking to. See full story here | | | | Continue Reading |
|
Markets | | | CarMax Beats, Accelerating Trends Support GrowthThe entire used car market has been in focus this year. The industry experienced a hiccup when the pandemic struck but quickly recovered and even began showing strength. The shift to pre-owned vehicles, driven by rising prices for new cars, was acceler... Read the Full Story |
|
Markets | | |
Pizza delivery chain Papa John’s International, Inc. (NASADQ: PZZA) shares spiked, peaked and sold-off making the benchmark S&P 500 index (NYSEARCA: SPY) appear to be standing still. Restaurants with off-premise and delivery sales channels have weathered the impacts of COVID-19. Pa... Read the Full Story |
|
From Our PartnersIncome expert Neil George has just released a new book called Income for Life.
Inside, it details more than 65 little-known income streams that ANYONE can collect
However, this book is not available for sale. Instead, we're on a nationwide campaign to spread the book far and wide for FREE. | | Click here to learn how to claim a copy. |
|
The Early Bird Stock Of The Day Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It also provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts. | | View Today's Stock Pick |
|
